It is interesting that the FDA would release this statement during trading hours. They knew the impact it would have on the stock and it makes it seem that was their intention. And it seems to make a statement to other countries why the FDA is not planning on approval for Leronlimab. Don’t think there is any need to speak politely in referring to the FDA in future CC.